Paper Details 
Original Abstract of the Article :
The safety and efficacy of amphotericin B lipid complex injection (ABELCET; Enzon Pharmaceuticals, Piscataway, NJ) was assessed in 548 children and adolescents 0-20 years of age who were enrolled in the Collaborative Exchange of Antifungal Research (CLEAR) registry. To our knowledge, this is the lar...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/01.inf.0000153183.51258.b8

データ提供:米国国立医学図書館(NLM)

Amphotericin B Lipid Complex: A Safe and Effective Treatment for Invasive Fungal Infections

The field of [Invasive Fungal Infection Treatment] is constantly searching for safe and effective therapies to combat these challenging conditions. This study examines the efficacy and safety of [Amphotericin B Lipid Complex (ABELCET)] in treating [Invasive Fungal Infections] in [children and adolescents]. The researchers analyzed data from the [Collaborative Exchange of Antifungal Research (CLEAR) registry], a comprehensive database of pediatric patients treated for invasive mycoses. Their findings indicate that [ABELCET demonstrated a favorable safety profile and effectiveness in treating invasive fungal infections in a large cohort of pediatric patients].

Navigating the Desert of Fungal Infections

This study offers valuable insights into the management of invasive fungal infections in children and adolescents, highlighting the effectiveness and safety of ABELCET in this vulnerable population. The findings emphasize the importance of having safe and effective treatment options for invasive fungal infections, particularly in pediatric patients.

A Beacon of Hope for Pediatric Patients

This study shines a beacon of hope in the desert of pediatric fungal infections, providing a safe and effective treatment option for this vulnerable population. The findings contribute to a better understanding of the management of invasive fungal infections in children and adolescents, leading to improved outcomes and quality of life.

Dr. Camel's Conclusion

This study demonstrates the effectiveness and safety of Amphotericin B Lipid Complex in treating invasive fungal infections in children and adolescents, offering a valuable tool for managing this challenging condition in a vulnerable population.

Date :
  1. Date Completed 2005-05-16
  2. Date Revised 2019-08-18
Further Info :

Pubmed ID

15702047

DOI: Digital Object Identifier

10.1097/01.inf.0000153183.51258.b8

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.